Dosing to rash: A phase II trial of the first-line erlotinib for patients with advanced non-small-cell lung cancer an Eastern Cooperative Oncology Group Study (E3503) von Brahmer, J.R, Lee, J.W, Traynor, A.M, Hidalgo, M.M, Kolesar, J.M, Siegfried, J.M, Guaglianone, P.P, Patel, J.D, Keppen, M.D, Schiller, J.H

Volltext

Acute leukemia after successful chemotherapy for oat cell carcinoma von Rose, V L, Keppen, M D, Eichner, E R, Pitha, J V, Murray, J L

Volltext